NRGene Technologies Ltd

Tel Aviv Stock Exchange NRGN.TA

NRGene Technologies Ltd Return on Equity (ROE) for the year ending December 31, 2023

NRGene Technologies Ltd Return on Equity (ROE) is NA for the year ending December 31, 2023. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • NRGene Technologies Ltd Return on Equity (ROE) for the year ending December 31, 2022 was -50.63%, a -7.37% change year over year.
  • NRGene Technologies Ltd Return on Equity (ROE) for the year ending December 31, 2021 was -47.16%.
Key data
Date Return on Equity (ROE) Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio
Market news
Loading...
SV Wall Street
Tel Aviv Stock Exchange: NRGN.TA

NRGene Technologies Ltd

CEO Dr. Gil Ronen Ph.D.
IPO Date Jan. 31, 2021
Location Israel
Headquarters Golda Meir Street
Employees 50
Sector Consumers Staples
Industries
Description

NRGene Technologies Ltd, an AI genomics company, provides computational tools and develops advanced algorithms in North America, Europe, Middle East, Africa, Asia Pacific, and internationally. It offers software tools; and turnkey solutions to breeding agricultural and food technology companies, academia, research institutes, and agribiotech companies. The company also develops custom panels for various plants including wheat, canola, corn, soybean, maize, etc., as well as cannabis. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.

StockViz Staff

February 6, 2025

Any question? Send us an email